User profiles for E. A. Goncharova

Elena Goncharova

Professor of Medicine, University of California, Davis
Verified email at ucdavis.edu
Cited by 4794

Aptamers as modular components of therapeutic nucleic acid nanotechnology

…, W Ke, J McMillan, EA Goncharova… - Therapeutic RNA …, 2021 - taylorfrancis.com
Nucleic acids play a central role in all domains of life, either as genetic blueprints or as
regulators of various biochemical pathways. The 826chemical makeup of ribonucleic acid (RNA) …

[HTML][HTML] Translational Advances in the Field of Pulmonary Hypertension.From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting …

…, R Savai, W Seeger, EA Goncharova - American journal of …, 2017 - atsjournals.org
Pulmonary arterial hypertension (PAH) has been frequently compared with a type of malignant
disease and has an incredible number of pathogenic mechanisms similar to cancer (1–3)…

[HTML][HTML] Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary …

EA Goncharova, DA Goncharov, A Eszterhas… - Journal of Biological …, 2002 - ASBMB
Although the cellular functions ofTSC2 and its protein product, tuberin, are not known, somatic
mutations in the TSC2 tumor suppressor gene are associated with tumor development in …

[HTML][HTML] mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects

EA Goncharova - The FASEB Journal, 2013 - ncbi.nlm.nih.gov
Goncharova 1 … Goncharova, EA mTOR and vascular remodeling in lung diseases: current …
, Ihida-Stansbury K., Jones PL, Goncharova EA (2011) mTOR is required for pulmonary arterial …

SIRT3–AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure …

…, CM St. Croix, A Garcia-Ocaña, EA Goncharova… - Circulation, 2016 - Am Heart Assoc
Background— Pulmonary hypertension associated with heart failure with preserved ejection
fraction (PH-HFpEF) is an increasingly recognized clinical complication of metabolic …

Vitamin D inhibits growth of human airway smooth muscle cells through growth factor‐induced phosphorylation of retinoblastoma protein and checkpoint kinase 1

…, HW Fogle, P Lim, EA Goncharova… - British journal of …, 2009 - Wiley Online Library
Background and purpose: Airway remodelling in asthma is manifested, in part, as increased
airway smooth muscle (ASM) mass, reflecting myocyte proliferation. We hypothesized that …

PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells

EA Goncharova, AJ Ammit, C Irani… - … of Physiology-Lung …, 2002 - journals.physiology.org
Human vascular smooth muscle cell proliferation and migration contribute to vascular remodeling
in pulmonary hypertension and atherosclerosis. The precise mechanisms that regulate …

Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial …

…, RM Tuder, SM Kawut, EA Goncharova - Circulation, 2014 - Am Heart Assoc
Background— Enhanced proliferation, resistance to apoptosis, and metabolic shift to
glycolysis of pulmonary arterial vascular smooth muscle cells (PAVSMCs) are key …

mTORC 1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts

…, D Álvarez, JC Sembrat, EA Goncharova… - Aging cell, 2016 - Wiley Online Library
Idiopathic pulmonary fibrosis ( IPF ) is a chronic, progressive, and usually lethal disease
associated with aging. However, the molecular mechanisms of the aging process that contribute …

mTORC2 is required for proliferation and survival of TSC2-null cells

EA Goncharova, DA Goncharov, H Li… - … and cellular biology, 2011 - Taylor & Francis
Mutational inactivation of the tumor suppressor tuberous sclerosis complex 2 (TSC2)
constitutively activates mTORC1, increases cell proliferation, and induces the pathological …